ReviewNature reviews. Cancer2015
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.
Christopher J Caunt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
373 papers cite itlatest 60 shown
this paperpooled ittrialcites it